4//SEC Filing
Gilley Thomas 4
Accession 0001437749-19-005627
CIK 0001019034other
Filed
Mar 24, 8:00 PM ET
Accepted
Mar 25, 5:28 PM ET
Size
7.1 KB
Accession
0001437749-19-005627
Insider Transaction Report
Form 4
Gilley Thomas
Director
Transactions
- Award
Common Stock
2019-03-21+424→ 19,384 total - Award
Stock Option (Right to Buy)
2019-03-21+2,500→ 2,500 totalExercise: $1.18Exp: 2026-03-20→ Common Stock (2,500 underlying)
Footnotes (2)
- [F1]Represents shares issued to the Reporting Person on March 21, 2019 under the Issuer's 2015 Equity Incentive Plan in payment of board committee meeting attendance fees.
- [F2]Represents shares issuable upon exercise of options granted to the Reporting Person on March 21, 2019 under the Issuer's 2015 Equity Incentive Plan. The options are exercisable at $1.18 per share, the last sale price of the Issuer's common stock as reported on the Nasdaq on the date of grant, have a term of seven years, and vest in three equal annual installments on each of the next three anniversaries of the grant date, subject to the Reporting Person's continued employment with or service to the Issuer through the applicable vesting date.
Documents
Issuer
BIO KEY INTERNATIONAL INC
CIK 0001019034
Entity typeother
Related Parties
1- filerCIK 0001599643
Filing Metadata
- Form type
- 4
- Filed
- Mar 24, 8:00 PM ET
- Accepted
- Mar 25, 5:28 PM ET
- Size
- 7.1 KB